These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17713031)

  • 1. Mast cells, T cells, and inhibition by luteolin: implications for the pathogenesis and treatment of multiple sclerosis.
    Theoharides TC; Kempuraj D; Iliopoulou BP
    Adv Exp Med Biol; 2007; 601():423-30. PubMed ID: 17713031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human mast cells stimulate activated T cells: implications for multiple sclerosis.
    Theoharides TC; Kempuraj D; Kourelis T; Manola A
    Ann N Y Acad Sci; 2008 Nov; 1144():74-82. PubMed ID: 19076366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells.
    Kempuraj D; Tagen M; Iliopoulou BP; Clemons A; Vasiadi M; Boucher W; House M; Wolfberg A; Theoharides TC
    Br J Pharmacol; 2008 Dec; 155(7):1076-84. PubMed ID: 18806808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis.
    Rohowsky-Kochan C; Molinaro D; Cook SD
    Mult Scler; 2000 Apr; 6(2):69-77. PubMed ID: 10773850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
    Elieh-Ali-Komi D; Cao Y
    Clin Rev Allergy Immunol; 2017 Jun; 52(3):436-445. PubMed ID: 28025778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients.
    Rozniecki JJ; Hauser SL; Stein M; Lincoln R; Theoharides TC
    Ann Neurol; 1995 Jan; 37(1):63-6. PubMed ID: 7818259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis.
    Zang YC; Hong J; Tejada-Simon MV; Li S; Rivera VM; Killian JM; Zhang JZ
    Eur J Immunol; 2000 Mar; 30(3):908-13. PubMed ID: 10741408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
    Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99).
    Hemmer B; Vergelli M; Calabresi P; Huang T; McFarland HF; Martin R
    J Neurosci Res; 1996 Sep; 45(6):852-62. PubMed ID: 8892097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha.
    Baram D; Vaday GG; Salamon P; Drucker I; Hershkoviz R; Mekori YA
    J Immunol; 2001 Oct; 167(7):4008-16. PubMed ID: 11564820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteolin as a therapeutic option for multiple sclerosis.
    Theoharides TC
    J Neuroinflammation; 2009 Oct; 6():29. PubMed ID: 19825165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.
    Lovett-Racke AE; Trotter JL; Lauber J; Perrin PJ; June CH; Racke MK
    J Clin Invest; 1998 Feb; 101(4):725-30. PubMed ID: 9466965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteolin Is More Potent than Cromolyn in Their Ability to Inhibit Mediator Release from Cultured Human Mast Cells.
    Tsilioni I; Theoharides T
    Int Arch Allergy Immunol; 2024; 185(8):803-809. PubMed ID: 38588651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis.
    Gregory GD; Robbie-Ryan M; Secor VH; Sabatino JJ; Brown MA
    Eur J Immunol; 2005 Dec; 35(12):3478-86. PubMed ID: 16285014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction and enhancement of Fc(epsilon)RI-dependent mast cell degranulation following coculture with activated T cells: dependency on ICAM-1- and leukocyte function-associated antigen (LFA)-1-mediated heterotypic aggregation.
    Inamura N; Mekori YA; Bhattacharyya SP; Bianchine PJ; Metcalfe DD
    J Immunol; 1998 Apr; 160(8):4026-33. PubMed ID: 9558112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Important role of mast cells in multiple sclerosis.
    Conti P; Kempuraj D
    Mult Scler Relat Disord; 2016 Jan; 5():77-80. PubMed ID: 26856948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelin reactive T cells in the autoimmune pathogenesis of multiple sclerosis.
    Stinissen P; Medaer R; Raus J
    Mult Scler; 1998 Jun; 4(3):203-11. PubMed ID: 9762675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing hormone and the blood-brain-barrier.
    Theoharides TC; Konstantinidou AD
    Front Biosci; 2007 Jan; 12():1615-28. PubMed ID: 17127408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate, T cells and multiple sclerosis.
    Levite M
    J Neural Transm (Vienna); 2017 Jul; 124(7):775-798. PubMed ID: 28236206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of interleukin-15 on effector and regulatory function of anti-CD3/anti-CD28-stimulated CD4(+) T cells.
    Lin SJ; Cheng PJ; Hsiao SS
    Bone Marrow Transplant; 2006 May; 37(9):881-7. PubMed ID: 16565741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.